Home » Topics » BioWorld Science

BioWorld Science
RSS

Tucatinib plus anti-HER2 antibody NSCs prolong survival of mice with brain-metastatic breast cancer

Jan. 10, 2022

Researchers publish data on DDR kinase inhibitor XBLJ-13 for pulmonary fibrosis

Jan. 10, 2022

Novel roe-inspired MSC microcapsules for the treatment of IBD

Jan. 10, 2022

Indirect radiolabeling of pGlu for intratumoral delivery of alpha- and beta-particle emitters

Jan. 10, 2022

Identification of novel drug candidates targeting dengue virus capsid protein

Jan. 10, 2022

Down syndrome linked to senescence-like state

Jan. 10, 2022

Unity Biotechnology eyes IND-enabling studies with pipeline programs in 2022

Jan. 7, 2022

Regulating fibrin-neutrophil interaction for controlling periodontitis

Jan. 7, 2022

Enanta expands respiratory virology program with EDP-323 for RSV

Jan. 7, 2022

LA-PAMAM/pmiR-218 polyplex as potential targeted gene therapy against HCC

Jan. 7, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...